Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine. - Wikidata - wikimedia - TriplyDB

Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine.

Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine.

http://www.wikidata.org/entity/Q34566739

about

Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents Attention deficit hyperactivity disorder and disordered eating behaviors: links, risks, and challenges faced Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy Magnesium, Iron, and Zinc Supplementation for the Treatment of Attention Deficit Hyperactivity Disorder: A Systematic Review on the Recent Literature Nutritional supplements for the treatment of ADHD Non-Pharmacological Treatments for ADHD in Youth Dietary patterns in children with attention deficit/hyperactivity disorder (ADHD)Zinc and the ERK kinases in the developing brain.Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder Brain-Delivery of Zinc-Ions as Potential Treatment for Neurological Diseases: Mini Review.The Relationship between Serum Vitamin D Level and Attention Deficit Hyperactivity Disorder.Pediatric Integrative Medicine Approaches to Attention Deficit Hyperactivity Disorder (ADHD)Iron, Magnesium, Vitamin D, and Zinc Deficiencies in Children Presenting with Symptoms of Attention-Deficit/Hyperactivity Disorder.Dietary and nutritional treatments for attention-deficit/hyperactivity disorder: current research support and recommendations for practitioners.Zinc for treating of children and adolescents with attention-deficit hyperactivity disorder: a systematic review of randomized controlled clinical trials.Mechanisms of behavioral, atopic, and other reactions to artificial food colors in children.Combination pharmacotherapy for psychiatric disorders in children and adolescents: prevalence, efficacy, risks and research needs.Research review: the role of diet in the treatment of attention-deficit/hyperactivity disorder--an appraisal of the evidence on efficacy and recommendations on the design of future studies.Diet in the treatment of ADHD in children - a systematic review of the literature.Oxidative and nitrosative stress in ADHD: possible causes and the potential of antioxidant-targeted therapies.Assessment of calcium and zinc accumulation in cultivated and wild apples.The Role of Nutritional Supplements in the Treatment of ADHD: What the Evidence Says.Updates on treatment of attention-deficit/hyperactivity disorder: facts, comments, and ethical considerations.Attention deficit hyperactivity disorder in children and adolescents.Rationale for Dietary Antioxidant Treatment of ADHD.

P2860

Q24186168-A9FF00C8-7873-4521-AF7A-07B33422ACC5 Q26752862-1A43AD2F-F80B-4B1D-A43C-F182CD00E1A9 Q26766330-05D18E2C-C382-4ED3-81FA-06CE32CA60F9 Q26786518-36E4F0FF-51D9-42DA-9C62-E1AF14174747 Q28247932-C376381E-1037-4799-B648-9E923C302764 Q30377445-C6496807-E893-4974-8F88-6F8F68D2CD5E Q33570441-977BEF50-D990-40B7-BC8D-CCC053980EF2 Q34233708-ED98E01A-55B0-457D-B7DA-994737237FED Q34413192-696DE7B3-EE23-419E-A159-A948DC16779F Q35561700-0D99A0FE-425C-4097-868E-E1CCFE2CE68A Q36350054-3C4FB060-95A5-4F16-9F5D-BFB282F55A90 Q37055817-B9B6788B-7202-4163-A6A9-ACD011A33C49 Q37055850-95C79052-0D59-4388-AFFB-DD25EA162592 Q37903750-16C048DC-0907-4877-B5FB-8FBDECAB572D Q38061364-DED8A2E1-48AC-4137-9668-E7195D556628 Q38099430-061DA6A0-4A5D-4C78-8B97-88F4D6CE584D Q38113748-A52029D4-67DE-446A-BC91-C6D61EA4A030 Q38189499-D6841CB3-657C-46E9-9630-5E9FE9D8D617 Q38220703-F7E02F2B-61D8-4797-87E6-DFC21C37DFEF Q38430387-2E7FB31B-0775-48D6-9EF6-D9127D453852 Q38753792-82FE213C-3EFE-43BE-BD6D-E4AB6C628017 Q39123700-8442D65F-A3B7-43BF-A65B-B982F00EA5F3 Q41473870-A244764E-1787-4D93-8988-D4B40430021A Q55217837-4497389E-21B9-4774-AB99-E3F1C1A1C282 Q55266001-E5EB09B8-CE68-440E-9F85-8F5B954A8034

P2860

Zinc for attention-deficit/hyperactivity disorder: placebo-controlled double-blind pilot trial alone and combined with amphetamine.

http://www.wikidata.org/entity/Q34566739

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Zinc for attention-deficit/hyp ...... and combined with amphetamine.

@ast

Zinc for attention-deficit/hyp ...... and combined with amphetamine.

@en

Zinc for attention-deficit/hyp ...... and combined with amphetamine.

@nl

type

label

Zinc for attention-deficit/hyp ...... and combined with amphetamine.

@ast

Zinc for attention-deficit/hyp ...... and combined with amphetamine.

@en

Zinc for attention-deficit/hyp ...... and combined with amphetamine.

@nl

prefLabel

Zinc for attention-deficit/hyp ...... and combined with amphetamine.

@ast

Zinc for attention-deficit/hyp ...... and combined with amphetamine.

@en

Zinc for attention-deficit/hyp ...... and combined with amphetamine.

@nl

P1433

Q34566739-94F3A7BA-2EA6-47AC-B7F3-7A3758DA057D

P1476

Q34566739-743FD44F-C7AE-46DC-B406-BAE5EC663ECD

P2093

Q34566739-05CCC92F-58B1-45AD-9417-A7468CD3983B

Q34566739-10B3C33B-769A-4582-98EC-A5B55448AAC6

Q34566739-19920E0D-91F6-4644-9626-85861964A689

Q34566739-4F32B285-66D6-4F2C-96B2-E0DA312ABFDD

Q34566739-66BC0AD9-533B-4349-B553-2369BDDB02E8

Q34566739-6F39C62D-FF2B-40DE-B72B-913BC15C67F9

Q34566739-995A45D9-F74E-48AE-9C61-F082850FB62E

Q34566739-A1742FD2-DDD5-4065-A08E-A9B78B71E37B

Q34566739-C3C69849-B5DF-43C7-87D1-A225E64127BD

Q34566739-C9A2524F-2A09-4AF5-846E-2C8CAAA047BD

P2860

Q34566739-09049E64-9B4F-4288-8D4E-EE44BA745B6F

Q34566739-1AFE9162-061F-438F-B0EC-5D50376FE7D6

Q34566739-22442910-37A8-4198-81BD-D57C82961966

Q34566739-285E487E-FDCC-4399-914C-43089E61E842

Q34566739-2E9883B0-2765-4266-930E-78C7EACFB508

Q34566739-4182BE0A-4C1E-4406-BBE2-4A250BB03CF7

Q34566739-49F1FC33-EC3A-409F-AD31-4D887498F01B

Q34566739-6B138E2B-F1F9-4978-9537-A8E8167DE4DF

Q34566739-8DCD98C6-F605-4B64-A06D-4F6A5537A84A

Q34566739-98A31BA8-A3CB-42CB-9506-436470801B66

P304

Q34566739-31967FF9-74C7-42E0-A29A-4D2B1BE3B883

P31

Q34566739-BFC8538B-ACE9-4FF1-9AB5-F1C52519BB79

P356

Q34566739-7EB25F64-A36B-47A0-916D-8CF9CA7B544D

P433

Q34566739-9FD46813-3AAF-41FF-A860-3F00C59D01BE

P478

Q34566739-769D67C8-CBB0-43D2-80FF-2E07E04DFA3D

P577

Q34566739-AF3BE28A-2FD1-413E-AF17-B425E5C12FD4

P5875

Q34566739-D5E22441-3D04-4DEF-91C5-8CCB51A86D78

P698

Q34566739-8EE09B9B-FF2B-4210-AE1B-AA2515837BD0

P921

Q34566739-B5A090C8-4D4A-48D6-950F-1A4EEAC8B1EE

Q34566739-CA920AC1-0121-4A43-A6C7-2E1BFDC944F2

Q34566739-FBA60661-EE97-446F-8610-C79CA37DEFC6

P932

Q34566739-351A5CE1-8D2D-4917-A1DC-438D6D148BE8

P356

P1433

Journal of Child and Adolescent Psychopharmacology

P1476

Zinc for attention-deficit/hyp ...... and combined with amphetamine.

@en

P2093

Dawn Bozzolo

http://www.w3.org/2001/XMLSchema#string

Elizabeth Joseph

http://www.w3.org/2001/XMLSchema#string

Hernan Bozzolo

http://www.w3.org/2001/XMLSchema#string

L Eugene Arnold

http://www.w3.org/2001/XMLSchema#string

Lindsay Crowl

http://www.w3.org/2001/XMLSchema#string

Mahmoud Abdel-Rasoul

http://www.w3.org/2001/XMLSchema#string

Robert A Disilvestro

http://www.w3.org/2001/XMLSchema#string

Soledad Fernandez

http://www.w3.org/2001/XMLSchema#string

Susan Thompson

http://www.w3.org/2001/XMLSchema#string

Xiaokui Mo

http://www.w3.org/2001/XMLSchema#string

P2860

Zinc deficiency and child development

Zinc sulfate as an adjunct to methylphenidate for the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial [ISRCTN64132371]

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.

Randomized trial of the effect of zinc supplementation on the mental health of school-age children in Guatemala.

Dietary intake, dietary patterns, and changes with age: an epidemiological perspective.

Current status of zinc in health and disease states.

Assessment of zinc status.

Role of zinc in the pathogenesis of attention-deficit hyperactivity disorder: implications for research and treatment.

Use and abuse of the Children's Depression Inventory.

Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior.

P304

1-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/CAP.2010.0073

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49825271

http://www.w3.org/2001/XMLSchema#string

P698

21309695

http://www.w3.org/2001/XMLSchema#string

P921

attention deficit hyperactivity disorder

P932

3037197

http://www.w3.org/2001/XMLSchema#string